SAS Output

21-JUL-2017 18:10

BREAST ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1007-Breast,Adj,N1,Endocrine+/-Chemo 1 Y 1 Recurrence Score testing 9400 9252 799 420 203 68 16 02/28/2011 408 206
            9252 799 420 203 68 16      
 
    2 Y 2 Chemo and Endocrine Therapy 4000 2493 272 138 71 22 6 02/28/2011    
        3 Endocrine Therapy Alone   2483 276 145 71 21 7      
            4976 548 283 142 43 13      
 
  S1207-Brst,Adj,Endocrine+/-Everolimus 1 Y 1 Blinded drug + Endocrine 1900 647 222 114 53 18 7 09/12/2013 485 248
        2 Blinded drug + Endocrine   641 213 111 50 17 4      
            1288 435 225 103 35 11      
 
  S1222-Brst,Fulv. +/- Ever. +/- Anastr. 1 T 1 Blinded treatment 840 12 0 0 0 0 0 05/15/2014 17 6
        2 Blinded treatment   12 0 0 0 0 0      
        3 Blinded treatment   13 0 0 0 0 0      
            37 0 0 0 0 0      
 
  S1416-Brst, TNBC/BRCA, Cis+/- ABT-888 1 Y 1 Blinded Drug + Cisplatin 333 56 56 44 22 7 2 09/15/2016 267 124
        2 Blinded Drug + Cisplatin   56 56 45 25 8 3      
            112 112 89 47 15 5      
 
  S1418-Breast, Adj, TNBC, MK-3475 (Pembrolizumab) 1 Y 1 Tissue for PD-L1 testing 1000 49 49 47 32 11 2 01/18/2017 366 149
            49 49 47 32 11 2      
 
    2 Y 2 Observation 1000 22 22 22 18 6 3 01/18/2017    
        3 MK-3475 (Pembrolizumab)   19 19 19 13 3 1      
            41 41 41 31 9 4      
 
Yes A011106-Breast, Neoadj, ALTERNATE study 1 E Total Registrations   41 21 11 7 3 1 04/29/2014 267 126
            41 21 11 7 3 1      
 
  E1Z11-Brst,Genetic Predictors of AIMSS 1 E Total Registrations   142 9 4 3 0 0 08/13/2013 270 95
            142 9 4 3 0 0      
 
No A011202-Breast, Nodal XRT +/- ALND 0 E Total Registrations   126 47 29 15 4 2 03/20/2014 333 175
            126 47 29 15 4 2      
 
    1 E Total Registrations   51 18 10 5 1 0 03/20/2014    
            51 18 10 5 1 0      
 
  A011203-Breast, Adv, Tam vs Endoxifen 0 E Total Registrations   9 1 1 0 0 0 08/14/2015 242 90
            9 1 1 0 0 0      
 
    1 E Total Registrations   7 1 1 0 0 0 08/14/2015    
            7 1 1 0 0 0      
 
    2 E Total Registrations   2 0 0 0 0 0 08/14/2015    
            2 0 0 0 0 0      
 
  A011401-Breast, adj, Stage II/III HER2-, weight loss 1 E Total Registrations   57 57 46 29 12 2 10/05/2016 261 147
            57 57 46 29 12 2      
 
    2 E Total Registrations   46 46 36 23 13 3 10/05/2016    
            46 46 36 23 13 3      
 
  B51-Breast, Regional Nodal XRT 1 E Total Registrations   15 7 6 3 1 0 06/13/2014 435 218
            15 7 6 3 1 0      
 
  B55-Brst, Adj Olaparib for BRCA,TNBC 1 E Total Registrations   41 20 10 4 0 0 12/15/2014 422 194
            41 20 10 4 0 0      
 
    2 E Total Registrations   18 9 7 3 0 0 12/15/2014    
            18 9 7 3 0 0      
 
  E2112-Brst,Adv,Exemestane+/-Entinostat 1 E Total Registrations   35 18 9 5 1 0 04/01/2015 296 165
            35 18 9 5 1 0      
 
  EA1131-Brst, TNBC, Post-op Chemo vs Obs 0 E Total Registrations   11 7 6 4 1 0 11/12/2015 294 127
            11 7 6 4 1 0      
 
    1 P Total Registrations   4 3 3 3 2 0 11/12/2015    
            4 3 3 3 2 0      
 
  NRGBR003-Brst,Adj,TNBC,AC -> WP +/- Carbo 1 E Total Registrations   38 22 12 10 2 0 10/16/2015 441 217
            38 22 12 10 2 0